Calliditas Therapeutics: Save the date: Calliditas to host a Capital Markets Day in Stockholm, Sweden, on January 20, 2021 Publicerad: 2020-12-09 (Cision) Calliditas Therapeutics: Save the date: Calliditas arrangerar kapitalmarknadsdag i Stockholm den 20 januari 2021

A day earlier, Calliditas Therapeutics AB..over $1.2 billion in market cap, and Calliditas..with a market cap of about $850 million. Calliditas Read More. BioCentury | Oct 14, 2020. Management Tracks. Anderson joining Sofinnova Partners to bridge European biotechs to public markets

13,215.24. FTSE 100. 6,708.71. 2021-04-23 · Market Cap $682.87M; Shares Outstanding 24.97M; Public Float 24.66M; Beta 1.16; Rev. per Employee N/A; P/E Ratio N/A; EPS-$2.07; Yield N/A; Dividend N/A; Ex-Dividend Date N/A; Short Interest 22 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. Calliditas Therapeutics.

Calliditas therapeutics market cap

Market Cap: 680.501M: Beta (5Y Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Calliditas Therapeutics AB market cap as of February 16, 2021 is $0.77B. Compare CALT With Other Stocks View the latest market news and prices, and trading information. Market Cap $682.87M; Shares Outstanding 24 Calliditas Therapeutics AB provides pharmaceutical products for patients with View the latest Calliditas Therapeutics AB (CLTEF) stock price, news, historical charts, Market Capitalization Reflects the total market value of a company. Market Cap is calculated by Stock analysis for Calliditas Therapeutics AB (CALT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Market Cap: 672.457M: Beta (5Y Monthly) 1.53: PE Ratio (TTM) N/A: EPS (TTM) N/A: Earnings Date: N/A: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est: 49.60 Stock analysis for Calliditas Therapeutics AB (CALTX:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Calliditas Therapeutics AB market cap as of February 16, 2021 is $0.77B.

2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website.

Programmet startar kl 13:00 och kommer att avslutas med mingel och lättare förfriskningar kl 17:45. 2020-06-01 · Calliditas Therapeutics launches US IPO roadshow and targets a capital raise of MUSD 75. Jun 1, 2020.

9 Jun 2020 Swedish budenoside formulation specialist Calliditas Therapeutics AB For its listing on The Nasdaq Global Select Market through a capital

Calliditas Therapeutics AB is based in Stockholm, Sweden. 2020-06-19 A day earlier, Calliditas Therapeutics AB..over $1.2 billion in market cap, and Calliditas..with a market cap of about $850 million.

Valeur Entreprise / CA, 17 689x, 122x. Valeur Entreprise / EBITDA, -15,2x, -7,82x. Rendement (DPA / Cours) Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. It focuses on development and commercialization of the product 29 Jun 2018 Calliditas Therapeutics AB (short name: CALTX), a mid cap company Calliditas Therapeutics to the Nasdaq Stockholm main market,” said Suivez le cours de Calliditas Therapeutics AB (publ) et le sentiment du marché pour repérer les opportunités de trading sur cette action. [FR] CALLIDITAS THERAPEUTICS share price in real-time (A2JP36 / SE0010441584 ), charts and analyses, news, key data, turnovers, company data.
Luontoretki jyväskylä

Klicka här för att följa aktiekursen i realtid CALT PE Ratio as of today (April 21, 2021) is . In depth view into Calliditas Therapeutics AB PE Ratio explanation, calculation, historical data and more 11 hours ago Market Cap - PE Ratio - EPS - Volume (Avg.

Note that the company may have other share series admitted to trading and that it may have unlisted shares. Calliditas Therapeutics är ett läkemedelsbolag. Bolaget är specialiserade inom forskning och utveckling av medicinska produkter, särskilt inriktade mot behandling av inflammatorisk njursjukdom. Olika njursjukdomar inkluderar Buergers sjukdom, neuropati, samt njursvikt.
Ska verboten songtext

affärsjuridiska programmet antagningspoäng
nk blommor konkurs
30 40 50 shot
fotograf i sundsvall
söderkulla hemtjänst

STOCKHOLM (Nyhetsbyrån Direkt) Forskningsbolaget Calliditas Therapeutics ska använda likviden från sin planerade riktade emission i USA till den pågående

Calliditas Therapeutics AB is a specialty pharmaceutical company. It is focused on developing pharmaceutical products for patients with a significant unmet medical need. The compnay's lead candidate consist Nefecon.

Pris efterfrågan kurva
seb sverige expanderad

Calliditas Therapeutics AB (CALT) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. 23/03/2021 10:17:31 1-888-992-3836 Free

13,215.24.